185 related articles for article (PubMed ID: 36194905)
1. Access and quality of biomarker testing for precision oncology in Europe.
Normanno N; Apostolidis K; Wolf A; Al Dieri R; Deans Z; Fairley J; Maas J; Martinez A; Moch H; Nielsen S; Pilz T; Rouleau E; Patton S; Williams V
Eur J Cancer; 2022 Nov; 176():70-77. PubMed ID: 36194905
[TBL] [Abstract][Full Text] [Related]
2. ESMO study on the availability and accessibility of biomolecular technologies in oncology in Europe.
Bayle A; Bonastre J; Chaltiel D; Latino N; Rouleau E; Peters S; Galotti M; Bricalli G; Besse B; Giuliani R
Ann Oncol; 2023 Oct; 34(10):934-945. PubMed ID: 37406812
[TBL] [Abstract][Full Text] [Related]
3. Molecular tests and target therapies in oncology: recommendations from the Italian workshop.
Pinto C; Biffoni M; Popoli P; Marchetti A; Marchetti P; Martini N; Normanno N
Future Oncol; 2021 Sep; 17(26):3529-3539. PubMed ID: 34254524
[TBL] [Abstract][Full Text] [Related]
4. Precision cancer medicine: What has translated into clinical use in Belgium?
Delnord M; Van Valckenborgh E; Hebrant A; Antoniou A; Van Hoof W; Waeytens A; Van den Bulcke M
Semin Cancer Biol; 2022 Sep; 84():255-262. PubMed ID: 34129914
[TBL] [Abstract][Full Text] [Related]
5. Identifying the Steps Required to Effectively Implement Next-Generation Sequencing in Oncology at a National Level in Europe.
Horgan D; Curigliano G; Rieß O; Hofman P; Büttner R; Conte P; Cufer T; Gallagher WM; Georges N; Kerr K; Penault-Llorca F; Mastris K; Pinto C; Van Meerbeeck J; Munzone E; Thomas M; Ujupan S; Vainer GW; Velthaus JL; André F
J Pers Med; 2022 Jan; 12(1):. PubMed ID: 35055387
[TBL] [Abstract][Full Text] [Related]
6. Precision Oncology in Canada: Converting Vision to Reality with Lessons from International Programs.
Liu G; Cheung WY; Feilotter H; Manthorne J; Stockley T; Yeung M; Renouf DJ
Curr Oncol; 2022 Sep; 29(10):7257-7271. PubMed ID: 36290849
[TBL] [Abstract][Full Text] [Related]
7. Assessing the Cost-Effectiveness of Next-Generation Sequencing as a Biomarker Testing Approach in Oncology and Policy Implications: A Literature Review.
Mirza M; Goerke L; Anderson A; Wilsdon T
Value Health; 2024 May; ():. PubMed ID: 38729563
[TBL] [Abstract][Full Text] [Related]
8. Cancer Biomarkers in the era of precision oncology: Addressing the needs of patients and health systems.
Normanno N; Apostolidis K; de Lorenzo F; Beer PA; Henderson R; Sullivan R; Biankin AV; Horgan D; Lawler M
Semin Cancer Biol; 2022 Sep; 84():293-301. PubMed ID: 34389490
[TBL] [Abstract][Full Text] [Related]
9. Expert opinion on NSCLC small specimen biomarker testing - Part 2: Analysis, reporting, and quality assessment.
Penault-Llorca F; Kerr KM; Garrido P; Thunnissen E; Dequeker E; Normanno N; Patton SJ; Fairley J; Kapp J; de Ridder D; Ryška A; Moch H
Virchows Arch; 2022 Sep; 481(3):351-366. PubMed ID: 35857103
[TBL] [Abstract][Full Text] [Related]
10. Expert-based collaborative analysis of the situation and prospects of biomarker test implementation in oncology in Spain.
Mestre-Ferrándiz J; Franch Camino B; Hidalgo Á; Del Llano Núñez-Cortés A; Del Llano Señarís JE; Lumbreras B; Beas Pedraza D; Nuño-Solinís R; Paz-Ares L; Ramón Y Cajal S; Rodríguez MJ
Clin Transl Oncol; 2024 Apr; 26(4):985-990. PubMed ID: 38206517
[TBL] [Abstract][Full Text] [Related]
11. Real-World Data on NGS Diagnostics: a survey from the Italian Society of Pathology (SIAPeC) NGS Network.
Marchetti A; Barbareschi M; Barberis M; Buglioni S; Buttitta F; Fassan M; Fontanini G; Marchiò C; Papotti M; Pruneri G; Scarpa A; Stanta G; Tallini G; Troncone G; Veronese SM; Truini M; Sapino A
Pathologica; 2021 Aug; 113(4):262-271. PubMed ID: 34463674
[TBL] [Abstract][Full Text] [Related]
12. Next generation diagnostic molecular pathology: critical appraisal of quality assurance in Europe.
Dubbink HJ; Deans ZC; Tops BB; van Kemenade FJ; Koljenović S; van Krieken HJ; Blokx WA; Dinjens WN; Groenen PJ
Mol Oncol; 2014 Jun; 8(4):830-9. PubMed ID: 24704265
[TBL] [Abstract][Full Text] [Related]
13. An Approach to Solving the Complex Clinicogenomic Data Landscape in Precision Oncology: Learnings From the Design of WAYFIND-R, a Global Precision Oncology Registry.
Le Tourneau C; Perret C; Hackshaw A; Blay JY; Nabholz C; Geissler J; Do T; von Meyenn M; Dienstmann R
JCO Precis Oncol; 2022 Jul; 6():e2200019. PubMed ID: 35939770
[TBL] [Abstract][Full Text] [Related]
14. American Society of Clinical Oncology policy statement update: genetic testing for cancer susceptibility.
American Society of Clinical Oncology
J Clin Oncol; 2003 Jun; 21(12):2397-406. PubMed ID: 12692171
[TBL] [Abstract][Full Text] [Related]
15. Bringing Greater Accuracy to Europe's Healthcare Systems: The Unexploited Potential of Biomarker Testing in Oncology.
Horgan D; Ciliberto G; Conte P; Baldwin D; Seijo L; Montuenga LM; Paz-Ares L; Garassino M; Penault-Llorca F; Galli F; Ray-Coquard I; Querleu D; Capoluongo E; Banerjee S; Riegman P; Kerr K; Horbach B; Büttner R; Van Poppel H; Bjartell A; Codacci-Pisanelli G; Westphalen B; Calvo F; Koeva-Balabanova J; Hall S; Paradiso A; Kalra D; Cobbaert C; Varea Menendez R; Maravic Z; Fotaki V; Bennouna J; Cauchin E; Malats N; Gutiérrez-Ibarluzea I; Gannon B; Mastris K; Bernini C; Gallagher W; Buglioni S; Kent A; Munzone E; Belina I; Van Meerbeeck J; Duffy M; Sarnowska E; Jagielska B; Mee S; Curigliano G
Biomed Hub; 2020; 5(3):182-223. PubMed ID: 33564664
[TBL] [Abstract][Full Text] [Related]
16. [Significance of participation in programs of external quality assessment in molecular diagnostic--our experience].
Paro MM; Siftar Z; Juretić D; Flegar-Mestrić Z
Acta Med Croatica; 2011 Sep; 65 Suppl 1():105-14. PubMed ID: 23126037
[TBL] [Abstract][Full Text] [Related]
17. Accreditation, setting and experience as indicators to assure quality in oncology biomarker testing laboratories.
Tack V; Schuuring E; Keppens C; Hart N'; Pauwels P; van Krieken H; Dequeker EMC
Br J Cancer; 2018 Aug; 119(5):605-614. PubMed ID: 30140047
[TBL] [Abstract][Full Text] [Related]
18. Biomarker testing and mutation prevalence in metastatic colorectal cancer patients in five European countries using a large oncology database.
Kafatos G; Banks V; Burdon P; Neasham D; Anger C; Manuguid F; Lowe KA; Cheung P; Taieb J; van Krieken JH
Future Oncol; 2021 Apr; 17(12):1483-1494. PubMed ID: 33464119
[TBL] [Abstract][Full Text] [Related]
19. A Window Into Clinical Next-Generation Sequencing-Based Oncology Testing Practices.
Nagarajan R; Bartley AN; Bridge JA; Jennings LJ; Kamel-Reid S; Kim A; Lazar AJ; Lindeman NI; Moncur J; Rai AJ; Routbort MJ; Vasalos P; Merker JD
Arch Pathol Lab Med; 2017 Dec; 141(12):1679-1685. PubMed ID: 29028368
[TBL] [Abstract][Full Text] [Related]
20. Non-Small Cell Lung Cancer in Countries of Central and Southeastern Europe: Diagnostic Procedures and Treatment Reimbursement Surveyed by the Central European Cooperative Oncology Group.
Ryska A; Buiga R; Fakirova A; Kern I; Olszewski W; Plank L; Seiwerth S; Toth E; Zivka E; Thallinger C; Zielinski C; Brcic L
Oncologist; 2018 Dec; 23(12):e152-e158. PubMed ID: 30076278
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
